Biomarin Pharmaceutical Inc
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 3,718 | 0.0% | 62,563 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 3,273 | 0.0% | 60,427 | 9/30/2025 |
| 2025 Q2 | 7/15/2025 | 3,292 | 0.0% | 59,895 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 4,164 | 0.0% | 58,907 | 3/31/2025 |
| 2024 Q4 | 2/19/2025 | 4,304 | 0.0% | 65,483 | 12/31/2024 |
| 2024 Q3 | 11/15/2024 | 4,858 | 0.0% | 69,113 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 6,251 | 0.0% | 75,932 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 6,767 | 0.0% | 77,481 | 3/31/2024 |
| 2023 Q4 | 2/16/2024 | 8,268 | 0.0% | 85,749 | 12/31/2023 |
| 2023 Q3 | 12/19/2023 | 7,523 | 0.0% | 85,027 | 9/30/2023 |
| 2023 Q2 | 12/19/2023 | 8,101 | 0.0% | 93,462 | 6/30/2023 |
| 2023 Q1 | 12/19/2023 | 9,776 | 0.0% | 100,537 | 3/31/2023 |
| 2022 Q4 | 12/19/2023 | 9,833 | 0.0% | 95,012 | 12/31/2022 |
| 2022 Q3 | 11/15/2022 | 7,959 | 0.0% | 93,884 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 7,721 | 0.0% | 93,173 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 7,409 | 0.0% | 96,096 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 8,777 | 0.0% | 99,347 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 7,956 | 0.0% | 102,943 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 8,768 | 0.0% | 105,076 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 7,451 | 0.0% | 98,671 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 8,020 | 0.0% | 91,460 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 5,641 | 0.0% | 74,143 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 8,570 | 0.0% | 69,482 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 6,138 | 0.0% | 72,639 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 5,213 | 0.0% | 61,660 | 12/31/2019 |
| 2014 Q1 | 5/15/2014 | 3,263 | 0.0% | 47,840 | 3/31/2014 |
| 2013 Q4 | 2/14/2014 | 4,030 | 0.0% | 57,344 | 12/31/2013 |